Immune cell infiltration has emerged as a prognostic marker for CRC, with CD4+ and CD8+ T cells being particularly favorable prognostic factors, correlating with chemotherapy and immunotherapy sensitivity. The gene discussed is CD8A; the disease is colorectal carcinoma.